UK pharma and integrated health
A new whitepaper presenting analysis of exclusive M3 (EU) data, revealing the digital and technological habits and preferences of doctors and how pharma can best engage.
Join us for a one-hour live webinar entitled Brexit – What now for pharma?
Available on Demand: Measuring the cost of the right interventions in diabetes.
Available on demand: A one-hour live debate on Cancer Treatment Access: Right Strategy, Right Approach, Right Outcomes.